Testing effectiveness (Phase 2)Study completedNCT03631407
What this trial is testing
Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Microsatellite Stable (MSS) Colorectal Cancer (CRC) (MK-7690-046)
Who this might be right for
Colorectal Neoplasms
Merck Sharp & Dohme LLC 41